| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Community Narratives
Narratives bring a range of perspectives from our community.
WA
WarrenAI
Based on Analyst Price Targets
Innovative Insurance Strategies Poised To Revolutionize Market Presence And Profitability
US$26.80
FV
19.4% undervalued intrinsic discount23.87%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
5 days agoauthor updated this narrative
Oscar Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$21.61 |
| 52 Week High | US$23.44 |
| 52 Week Low | US$4.72 |
| Beta | 1.61 |
| 11 Month Change | 18.74% |
| 3 Month Change | 13.74% |
| 1 Year Change | 251.38% |
| 33 Year Change | 23.49% |
| 5 Year Change | n/a |
| Change since IPO | -37.90% |
Recent News & Updates
Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Just Yet
Sep 13
Oscar Health: At Nearly 4x Book Value Investors Should Wait For A Pullback
Sep 03Recent updates
Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Just Yet
Sep 13Oscar Health: At Nearly 4x Book Value Investors Should Wait For A Pullback
Sep 03Oscar Health: Achieves Profitability In Q1 2024, But Uncertainties Remain
Jul 02Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 11Investors Still Aren't Entirely Convinced By Oscar Health, Inc.'s (NYSE:OSCR) Revenues Despite 30% Price Jump
May 03Oscar Health: Strong Industry Catalyst With Margin Expansion Potential
Apr 13This Analyst Just Made An Upgrade To Their Oscar Health, Inc. (NYSE:OSCR) Earnings Forecasts
Feb 12Oscar Health, Inc. (NYSE:OSCR) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Feb 10Oscar Health: Flexible Business Model Is Paying Off
Jan 30Further Upside For Oscar Health, Inc. (NYSE:OSCR) Shares Could Introduce Price Risks After 37% Bounce
Jan 19Oscar Health, Inc. (NYSE:OSCR) Soars 49% But It's A Story Of Risk Vs Reward
Nov 21Oscar Health: Q3 Earnings Suggest Growth Can Continue Into 2024
Nov 15Oscar Health: Decreasing Memberships Is Worrying
Sep 22Oscar Health Shares Quadrupled, But They Are Still Cheap
Jul 03Oscar Health: High Growth And Improving Profitability Make It A Buy
Jun 15Oscar Health Insurance GAAP EPS of -$1.05 beats by $0.03, revenue of $995M misses by $415M
Feb 09Oscar Health: Wait For Concrete Evidence The Business Can Turn Profitable
Jan 18Oscar Health Is Back On Track
Nov 11Oscar Health: Improving Risk/Reward Profile To Watch
Oct 03Florida health insurer terminating agreement with Oscar Health
Aug 30Oscar Health Grows Revenue But Needs Progress To Profitability
Jul 08Shareholder Returns
| OSCR | US Insurance | US Market | |
|---|---|---|---|
| 7D | 27.2% | -0.5% | 1.6% |
| 1Y | 251.4% | 30.6% | 22.0% |
Return vs Industry: OSCR exceeded the US Insurance industry which returned 30.6% over the past year.
Return vs Market: OSCR exceeded the US Market which returned 22% over the past year.
Price Volatility
| OSCR volatility | |
|---|---|
| OSCR Average Weekly Movement | 9.4% |
| Insurance Industry Average Movement | 4.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: OSCR's share price has been volatile over the past 3 months.
Volatility Over Time: OSCR's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 2,400 | Mark Bertolini | www.hioscar.com |
Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Oscar Health, Inc. Fundamentals Summary
| OSCR fundamental statistics | |
|---|---|
| Market cap | US$5.07b |
| Earnings (TTM) | US$18.15m |
| Revenue (TTM) | US$7.23b |
287.7x
P/E Ratio0.7x
P/S RatioIs OSCR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OSCR income statement (TTM) | |
|---|---|
| Revenue | US$7.23b |
| Cost of Revenue | US$5.63b |
| Gross Profit | US$1.60b |
| Other Expenses | US$1.58b |
| Earnings | US$18.15m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.075 |
| Gross Margin | 22.12% |
| Net Profit Margin | 0.25% |
| Debt/Equity Ratio | 26.2% |
How did OSCR perform over the long term?
See historical performance and comparison